Skip to content
healthcare.dev

LISDEXAMFETAMINE DIMESYLATE

NDC 31722-356, Lisdexamfetamine dimesylate, capsule, from Camber Pharmaceuticals, Inc..

Product NDC
31722-356
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217442
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-356 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE70 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
31722-356-0131722035601100 CAPSULE in 1 BOTTLE (31722-356-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/20baa61e-be0b-41a3-a896-29e8ce8c4799
  • NADAC price for package 31722035601

    GET /v1/drugs/nadac/31722035601

Use it

Look up 31722-356 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-356 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-356. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.